AQR Capital Management
RCEL icon

AQR Capital Management’s Avita Medical RCEL Stock Holding History

AQR Capital Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$349K Sell
94,361
-7,131
-7% -$29.9K ﹤0.01% 3333
2025
Q4 		$350K Sell
101,492
-17,796
-15% -$71K ﹤0.01% 3103
2025
Q3 		$610K Buy
119,288
+97,365
+444% +$508K ﹤0.01% 2711
2025
Q2 		$116K Sell
21,923
-76,214
-78% -$554K ﹤0.01% 3152
2025
Q1 		$799K Buy
+98,137
New +$917K ﹤0.01% 2166
2024
Q4 		– Sell
-15,957
Closed -$171K – 2933
2024
Q3 		$171K Sell
15,957
-7,108
-31% -$66.8K ﹤0.01% 2593
2024
Q2 		$183K Sell
23,065
-67,535
-75% -$642K ﹤0.01% 2438
2024
Q1 		$1.45M Buy
90,600
+28,391
+46% +$459K ﹤0.01% 1537
2023
Q4 		$854K Buy
62,209
+51,967
+507% +$596K ﹤0.01% 1657
2023
Q3 		$150K Buy
+10,242
New +$173K ﹤0.01% 2182
2022
Q3 		– Sell
-10,086
Closed -$48K – 2298
2022
Q2 		$48K Buy
+10,086
New +$62.3K ﹤0.01% 2137

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AQR Capital Management's RCEL Position: Q1 2026 in Review

AQR Capital Management reduced its Avita Medical (RCEL) stake by 7% in Q1 2026, selling an estimated $29.9K and leaving 94,361 shares worth $349K. The position accounts for ﹤0.01% of the portfolio, ranked #3333.

AQR Capital Management first reported a position in RCEL in Q2 2022 and has held it in 11 quarters since. The position peaked at $1.45M in Q1 2024. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • AQR Capital Management held 94,361 shares of Avita Medical worth $349K as of Q1 2026.
  • AQR Capital Management sold 7,131 Avita Medical shares in Q1 2026, an estimated $29.9K.
  • Avita Medical made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #3333 holding.
  • AQR Capital Management first reported a position in Avita Medical in Q2 2022 and has held it in 11 quarters since.
  • AQR Capital Management's Avita Medical position peaked at $1.45M in Q1 2024.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.